GHK-Cu is typically associated with collagen signaling, skin remodeling, and tissue regeneration, while BPC-157 is more often discussed in relation to tendon, ligament, muscle, gut, and musculoskeletal recovery models
Functional medicine providers typically use them with periodic cognitive assessment and monitoring of relevant biomarkers
Cash-pay billing that doesnt create insurance fraud exposure
The clinical trial protocol starts at 0.25 mg to 0.3 mg weekly and increases every 4 weeks through escalation steps of 0.6 mg, 1.2 mg, 1.8 mg, and finally 2.4 mg
Fresh activation ensures the peptide is mixed immediately before use, helping preserve product quality and potency throughout its lifecycle